Industry Press Releases

May 9, 2017 | Industry Press Releases
Abbott Announces CE Mark for Tacticath™ Contact Force Ablation Catheter, Sensor Enabled™

“Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a condition in which the upper chambers of the heart beat too fast. When integrated with Abbott’s EnSite Precision™ cardiac mapping system, physicians are able […]

May 9, 2017 | Industry Press Releases
ABBOTT ANNOUNCES CE MARK FOR TACTICATH™ CONTACT FORCE ABLATION CATHETER, SENSOR ENABLED™

“Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a condition in which the upper chambers of the heart beat too fast.”

May 8, 2017 | Industry Press Releases
Abbott Announces National Reimbursement for Freestyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes

“Abbott today announced that the French Health Ministry has granted national reimbursement across France for FreeStyle® Libre—Abbott’s revolutionary glucose monitoring technology that removes the need for routine finger sticks1 for people with diabetes. This reimbursement decision will mean access to the FreeStyle Libre system for hundreds of thousands of people from age four3 across France […]

May 8, 2017 | Industry Press Releases
Abbott Announces CE Mark and First Use of the World’s First Smartphone Compatible Insertable Cardiac Monitor

“Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy. Since CE Mark approval, adoption of the device has been strong and […]

May 1, 2017 | Industry Press Releases
Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

“Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx(TM) Drug-Eluting Stent (DES). The Resolute Onyx DES builds on the proven clinical performance and superior deliverability of the Resolute Integrity(TM) DES to further strengthen the gold standard safety and efficacy of DES technology…”

Mar 7, 2017 | Industry Press Releases
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control Unit 4.0. The EKOS® system includes an ultrasonic device that uses acoustic pulses, powered by the new Control Unit 4.0, to quickly and safely dissolve blood clots and restore blood […]

Filter by Journal

X